Rare diseases
Investigational molecules
Locations
Back to Poland1 824 clinical trials in Warsaw, Poland across 33 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)Study Comparing Rinatabart Sesutecan with Other Treatments for Patients with Platinum-Resistant Ovarian Cancer
PolandStudy of ENTR-601-45 Safety and Effectiveness in Patients with Duchenne Muscular Dystrophy Who Can Skip Exon 45
PolandStudy Comparing Zilovertamab Vedotin with Drug Combination for Untreated Patients with Diffuse Large B-Cell Lymphoma
PolandStudy on Long-term Safety of Zasocitinib for Adults with Moderate to Severe Ulcerative Colitis and Crohn's Disease
PolandStudy of lisaftoclax combined with azacitidine for elderly patients with newly diagnosed acute myeloid leukemia
PolandStudy on the Safety and Effectiveness of Emicizumab for Patients with TYPE 3 Von Willebrand Disease
PolandStudy of ENTR-601-44 in Children with Duchenne Muscular Dystrophy Who Are Eligible for Exon 44 Skipping Treatment
PolandStudy of L-Annamycin and Cytarabine for Adults with Refractory or Relapsed Acute Myeloid Leukemia
PolandStudy of Trastuzumab Deruxtecan and Drug Combination for Patients with Advanced or Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer
PolandStudy on IV NEPA (Fosnetupitant/Palonosetron) for Preventing Chemotherapy-Induced Nausea and Vomiting in Pediatric Cancer Patients
PolandStudy of HLX22, Trastuzumab, and Chemotherapy for Patients with Advanced or Metastatic Stomach and Gastroesophageal Cancer
PolandStudy on the Effectiveness and Safety of RO7790121 for Patients with Moderate to Severe Crohn's Disease
PolandThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) prevention in older adults. Studies include evaluation of novel vaccine formulations and immune responses in various age groups.
Particular emphasis on vaccine development for adults aged 60 and older.
Comprehensive research on meningococcal vaccines across different age groups, from infants to toddlers. Studies evaluate safety profiles and immune responses to various vaccine formulations.
Focus on preventive healthcare through advanced vaccination strategies.
Studies investigating treatments for psoriasis and psoriatic arthritis, including novel biological therapies and their mechanisms of action.
Emphasis on moderate to severe cases requiring advanced therapeutic interventions.
Clinical research focusing on bladder cancer and innovative combination therapies. Studies evaluate treatment efficacy in early-stage non-muscle invasive cases.
Integration of targeted therapies with standard treatments.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
